Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Neurocritical Care
Published in: Neurocritical Care 1/2017

01-08-2017 | Original Article

Changes in Cerebral Perfusion with Induced Hypertension in Aneurysmal Subarachnoid Hemorrhage: A Pilot and Feasibility Study

Authors: Amanda Murphy, Airton Leonardo de Oliveira Manoel, R. Loch Macdonald, Andrew Baker, Ting-Yim Lee, Tom Marotta, Walter Montanera, Richard Aviv, Aditya Bharatha

Published in: Neurocritical Care | Issue 1/2017

Login to get access

Abstract

Background

The effects of induced hypertension (IH) on cerebral perfusion after subarachnoid hemorrhage (SAH) are unclear. The objectives of this investigation are to: (1) determine whether there are differences in cerebral blood flow (CBF), cerebral blood volume (CBV), and mean transit time (MTT) measured with computed tomography perfusion (CTP) before and after IH; (2) evaluate differences in the presence of infarction and clinical outcome between patients with and without IH.

Methods

We performed a retrospective cohort analysis of 25 aneurysmal SAH patients. IH was initiated as per the standard institutional protocol when patients showed clinical symptoms of delayed cerebral ischemia (DCI). Differences in CBF, CBV, and MTT between early (<72 h after aneurysm rupture) and late (7–10 days after aneurysm rupture) CTP were quantified in patients with (n = 13) and without IH (n = 12). Outcome measures included cerebral infarction and clinical outcome at 3 months.

Results

Early MTT was significantly greater in the IH group compared to the no-IH group. There was no difference in early or late CBV or CBF between the two groups. In patients that received IH, there was a significant decrease in MTT between the early (7.0 ± 1.2 s) and late scans (5.8 ± 1.6 s; p = 0.005). There was no difference in the incidence of infarction (5/13 vs. 2/11) or poor outcome (3/11 vs. 6/13) between the IH and no-IH groups, respectively (p > 0.05).

Conclusions

Elevated MTT is a significant factor for the development of DCI in patients eventually requiring IH therapy and is improved by IH treatment. Therapies to prevent DCI and improve clinical outcome may need to be initiated earlier, when cerebral perfusion abnormalities are first identified.
Appendix
Available only for authorised users
Literature
1.
Tagami T, Kuwamoto K, Watanabe A, et al. Effect of triple-h prophylaxis on global end-diastolic volume and clinical outcomes in patients with aneurysmal subarachnoid hemorrhage. Neurocrit Care. 2014;21:462–9.CrossRefPubMed
2.
Treggiari MM, Walder B, Suter PM, et al. Systematic review of the prevention of delayed ischemic neurological deficits with hypertension, hypervolemia, and hemodilution therapy following subarachnoid hemorrhage. J Neurosurg. 2003;98:978–84.CrossRefPubMed
3.
Gathier CS, Dankbaar JW, van der Jagt M, et al. Effects of induced hypertension on cerebral perfusion in delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage: a randomized clinical trial. Stroke. 2015;46:3277–81.CrossRefPubMed
4.
Gathier CS, van den Bergh WM, Slooter AJ, et al. HIMALAIA (Hypertension Induction in the Management of AneurysmaL subArachnoid haemorrhage with secondary IschaemiA): a randomized single-blind controlled trial of induced hypertension vs. no induced hypertension in the treatment of delayed cerebral ischemia. Int J Stroke. 2014;9:375–80.CrossRefPubMed
5.
Connolly ES Jr, Rabinstein AA, Carhuapoma JR, et al. Guidelines for the management of aneurysmal subarachnoid hemorrhage: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2012;43:1711–37.CrossRefPubMed
6.
Diringer MN, Bleck TP, Hemphill Claude J, et al. Critical care management of patients following aneurysmal subarachnoid hemorrhage: recommendations from the neurocritical care society’s multidisciplinary consensus conference. Neurocrit Care. 2011;15:211–40.CrossRefPubMed
7.
Muench E, Horn P, Bauhuf C, et al. Effects of hypervolemia and hypertension on regional cerebral blood flow, intracranial pressure, and brain tissue oxygenation after subarachnoid hemorrhage. Crit Care Med. 2007;35:1844–51 (quiz 1852).CrossRefPubMed
8.
Origitano TC, Wascher TM, Reichman OH, et al. Sustained increased cerebral blood flow with prophylactic hypertensive hypervolemic hemodilution (“triple-H” therapy) after subarachnoid hemorrhage. Neurosurgery. 1990;27:729–40.CrossRefPubMed
9.
de Oliveira Manoel AL, Turkel-Parrella D, Duggal A, et al. Managing aneurysmal subarachnoid hemorrhage: it takes a team. Cleve Clin J Med. 2015;82:177–92.CrossRefPubMed
10.
Vergouwen MD, Vermeulen M, van Gijn J, et al. Definition of delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage as an outcome event in clinical trials and observational studies: proposal of a multidisciplinary research group. Stroke. 2010;41:2391–5.CrossRefPubMed
11.
Tatu L, Moulin T, Vuillier F, et al. Arterial territories of the human brain. Front Neurol Neurosci. 2012;30:99–110.CrossRefPubMed
12.
Murphy A, de Oliveira Manoel AL, Burgers K, et al. Early CT perfusion changes and blood-brain barrier permeability after aneurysmal subarachnoid hemorrhage. Neuroradiology. 2015;. doi:10.​1007/​s00234-015-1529-1.
13.
Sakr Y, Dunisch P, Santos C, et al. Poor outcome is associated with less negative fluid balance in patients with aneurysmal subarachnoid hemorrhage treated with prophylactic vasopressor-induced hypertension. Ann Intensive Care 2016;6:25–016–0128–6 (Epub 2016 Mar 31).
14.
Dankbaar JW, Slooter AJ, Rinkel GJ, et al. Effect of different components of triple-H therapy on cerebral perfusion in patients with aneurysmal subarachnoid haemorrhage: a systematic review. Crit Care. 2010;14:R23.CrossRefPubMedPubMedCentral
15.
Rinkel GJ. Management of patients with aneurysmal subarachnoid haemorrhage. Curr Opin Neurol. 2016;29:37–41.CrossRefPubMed
16.
Meyer R, Deem S, Yanez ND, et al. Current practices of triple-H prophylaxis and therapy in patients with subarachnoid hemorrhage. Neurocrit Care. 2011;14:24–36.CrossRefPubMed
17.
Muhammad S, Guresir A, Greschus S, et al. Posterior reversible encephalopathy syndrome as an overlooked complication of induced hypertension for cerebral vasospasm: systematic review and illustrative case. Stroke. 2016;47:519–22.CrossRefPubMed
18.
Dankbaar JW, de Rooij NK, Smit EJ, et al. Changes in cerebral perfusion around the time of delayed cerebral ischemia in subarachnoid hemorrhage patients. Cerebrovasc Dis. 2011;32:133–40.CrossRefPubMed
19.
Sanelli PC, Anumula N, Johnson CE, et al. Evaluating CT perfusion using outcome measures of delayed cerebral ischemia in aneurysmal subarachnoid hemorrhage. AJNR Am J Neuroradiol. 2013;34:292–8.CrossRefPubMed
20.
Killeen RP, Gupta A, Delaney H, et al. Appropriate use of CT perfusion following aneurysmal subarachnoid hemorrhage: a bayesian analysis approach. AJNR Am J Neuroradiol. 2014;35:459–65.CrossRefPubMed
21.
Konstas AA, Goldmakher GV, Lee TY, et al. Theoretic basis and technical implementations of CT perfusion in acute ischemic stroke, part 1: theoretic basis. Am J Neuroradiol. 2009;30:662–8.CrossRefPubMed
22.
Etminan N, Beseoglu K, Heiroth HJ, et al. Early perfusion computerized tomography imaging as a radiographic surrogate for delayed cerebral ischemia and functional outcome after subarachnoid hemorrhage. Stroke. 2013;44:1260–6.CrossRefPubMed
23.
Wartenberg KE, Parra A. CT and CT-perfusion findings of reversible leukoencephalopathy during triple-H therapy for symptomatic subarachnoid hemorrhage-related vasospasm. J Neuroimaging. 2006;16:170–5.CrossRefPubMed
Metadata
Title
Changes in Cerebral Perfusion with Induced Hypertension in Aneurysmal Subarachnoid Hemorrhage: A Pilot and Feasibility Study
Authors
Amanda Murphy
Airton Leonardo de Oliveira Manoel
R. Loch Macdonald
Andrew Baker
Ting-Yim Lee
Tom Marotta
Walter Montanera
Richard Aviv
Aditya Bharatha
Publication date
01-08-2017
Publisher
Springer US
Published in
Neurocritical Care / Issue 1/2017
Print ISSN: 1541-6933
Electronic ISSN: 1556-0961
DOI
https://doi.org/10.1007/s12028-017-0379-6

Other articles of this Issue 1/2017

Neurocritical Care 1/2017 Go to the issue

Original Article

Monitoring of Electrical Activity of the Diaphragm Shows Failure of T-Piece Trial Earlier than Protocol-Based Parameters in Prolonged Weaning in Non-communicative Neurological Patients

Original Article

An Association Between ICP-Derived Data and Outcome in TBI Patients: The Role of Sample Size

A day in the life of a fellow

Ruptured MCA Aneurysm Presenting as Intracerebral Hemorrhage

Current Concepts

Early Mobilization in the Neuro-ICU: How Far Can We Go?

Practical Pearl

Reverse Locked-In Syndrome

Original Article

Prevalence and Risk Factors for Early Seizure in Patients with Traumatic Brain Injury: Analysis from National Trauma Data Bank